Skip to main content
NCBI home page
Immunology logoLink to Immunology
. 1980 Jul;40(3):467–472.

Retinoids as regulators of macrophage function

J Rhodes, S Oliver
PMCID: PMC1458043  PMID: 7429540

Abstract

Retinol (vitamin A) and retinoic acid, at concentrations in the physiological range, were found to exert potent regulatory effects on the function of macrophages; suppressing the expression of Fc receptors and the subsequent phagocytosis of opsonized cells but enhancing production of the tumouricidal enzyme arginase. Another dietary essential lipid-soluble molecule, arachidonic acid, from which a number of active molecules known to regulate cellular function are derived, had no effect on macrophage receptor expression or phagocytosis.

Full text

PDF
467

Images in this article

469Figure 2
on p.469

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cohen B. E., Elin R. J. Vitamin A-induced nonspecific resistance to infection. J Infect Dis. 1974 May;129(5):597–600. doi: 10.1093/infdis/129.5.597. [DOI] [PubMed] [Google Scholar]
  2. Currie G. A. Activated macrophages kill tumour cells by releasing arginase. Nature. 1978 Jun 29;273(5665):758–759. doi: 10.1038/273758a0. [DOI] [PubMed] [Google Scholar]
  3. Currie G. A., Basham C. Differential arginine dependence and the selective cytotoxic effects of activated macrophages for malignant cells in vitro. Br J Cancer. 1978 Dec;38(6):653–659. doi: 10.1038/bjc.1978.270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dennert G., Crowley C., Kouba J., Lotan R. Retinoic acid stimulation of the induction of mouse killer T-cells in allogeneic and syngeneic systems. J Natl Cancer Inst. 1979 Jan;62(1):89–94. [PubMed] [Google Scholar]
  5. Dresser D. W. Adjuvanticity of vitamin A. Nature. 1968 Feb 10;217(5128):527–529. doi: 10.1038/217527a0. [DOI] [PubMed] [Google Scholar]
  6. Floersheim G. L., Bollag W. Accelerated rejection of skin homografts by vitamin A acid. Transplantation. 1972 Nov;14(5):564–567. doi: 10.1097/00007890-197211000-00006. [DOI] [PubMed] [Google Scholar]
  7. Huber P. R., Geyer E., Küng W., Matter A., Torhorst J., Eppenberger U. Retinoic acid-binding protein in human breast cancer and dysplasia. J Natl Cancer Inst. 1978 Dec;61(6):1375–1378. [PubMed] [Google Scholar]
  8. Jurin M., Tannock I. F. Influence of vitamin A on immunological response. Immunology. 1972 Sep;23(3):283–287. [PMC free article] [PubMed] [Google Scholar]
  9. Kung J. T., Brooks S. B., Jakway J. P., Leonard L. L., Talmage D. W. Suppression of in vitro cytotoxic response by macrophages due to induced arginase. J Exp Med. 1977 Sep 1;146(3):665–672. doi: 10.1084/jem.146.3.665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Levine L., Ohuchi K. Retinoids as well as tumour promoters enhance deacylation of cellular lipids and prostaglandin production in MDCK cells. Nature. 1978 Nov 16;276(5685):274–275. doi: 10.1038/276274a0. [DOI] [PubMed] [Google Scholar]
  11. Meltzer M. S., Cohen B. E. Tumor suppression by Mycobacterium bovis (strain BCG) enhanced by vitamin A. J Natl Cancer Inst. 1974 Aug;53(2):585–587. doi: 10.1093/jnci/53.2.585. [DOI] [PubMed] [Google Scholar]
  12. Polliack A., Sasson Z. B. Enhancing effect of excess topical vitamin A on Rous sarcomas in chickens. J Natl Cancer Inst. 1972 Feb;48(2):407–416. [PubMed] [Google Scholar]
  13. Rhodes J. Altered expression of human monocyte Fc receptors in malignant disease. Nature. 1977 Jan 20;265(5591):253–255. doi: 10.1038/265253a0. [DOI] [PubMed] [Google Scholar]
  14. Rhodes J., Bishop M., Benfield J. Tumor surveillance: how tumors may resist macrophage-mediated host defense. Science. 1979 Jan 12;203(4376):179–182. doi: 10.1126/science.758686. [DOI] [PubMed] [Google Scholar]
  15. Rhodes J. Macrophage heterogeneity in receptor activity: the activation of macrophage Fc receptor function in vivo and in vitro. J Immunol. 1975 Mar;114(3):976–981. [PubMed] [Google Scholar]
  16. Samuelsson B., Granström E., Green K., Hamberg M., Hammarström S. Prostaglandins. Annu Rev Biochem. 1975;44:669–695. doi: 10.1146/annurev.bi.44.070175.003321. [DOI] [PubMed] [Google Scholar]
  17. Schultz R. M., Pavlidis N. A., Stylos W. A., Chirigos M. A. Regulation of macrophage tumoricidal function: a role for prostaglandins of the E series. Science. 1978 Oct 20;202(4365):320–321. doi: 10.1126/science.694537. [DOI] [PubMed] [Google Scholar]
  18. Spitznagel J. K., Allison A. C. Mode of action of adjuvants: retinol and other lysosome-labilizing agents as adjuvants. J Immunol. 1970 Jan;104(1):119–127. [PubMed] [Google Scholar]
  19. Sporn M. B., Dunlop N. M., Newton D. L., Smith J. M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed Proc. 1976 May 1;35(6):1332–1338. [PubMed] [Google Scholar]
  20. Todaro G. J., De Larco J. E., Sporn M. B. Retinoids block phenotypic cell transformation produced by sarcoma growth factor. Nature. 1978 Nov 16;276(5685):272–274. doi: 10.1038/276272a0. [DOI] [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES